Elimination of CD4+CD25+ Regulatory T Cells in Patients With Hepatocellular Carcinoma
NCT00396682
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Advanced HCC
Interventions
DRUG:
Cyclophosphamide
Sponsor
Hannover Medical School